Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain

Effect of IgG from seronegative and seropositive neuromyelitis optica patients on mouse brain

Bibliographic Details
Main Authors:	Saadoun, S, Waters, P, Bennett, J, Vincent, A, Papadopoulos, M
Format:	Conference item
Published:	2013

Similar Items

Neuromyelitis optica IgG causes placental inflammation and fetal death.
by: Saadoun, S, et al.
Published: (2013)

Neuromyelitis optica IgG causes placental inflammation and fetal death in mice
by: Saadoun, S, et al.
Published: (2013)

NMO-IgG in the diagnosis of neuromyelitis optica.
by: Jarius, S, et al.
Published: (2007)

IgG subclasses of disease-specific antibodies and complement activation in-vitro in seronegative myasthenia gravis and neuromyelitis optica
by: Jacob, S, et al.
Published: (2008)

Devic's neuromyelitis optica: Prognostic implications of NMO IgG status in Turkish patients
by: Akman-Demir, G, et al.
Published: (2008)

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain
by: Saadoun, S, et al.
Published: (2012)

Neutrophil protease inhibition reduces neuromyelitis optica-immunoglobulin G-induced damage in mouse brain.
by: Saadoun, S, et al.
Published: (2012)

Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice.
by: Saadoun, S, et al.
Published: (2010)

Revised diagnostic criteria for neuromyelitis optica--incorporation of NMO-IgG status.
by: Jarius, S, et al.
Published: (2007)

An audit of the diagnostic usefulness of the NMO-IgG assay for neuromyelitis optica
by: Littleton, E, et al.
Published: (2006)

Cytotoxic edema in a patient with neuromyelitis optica: This may be suggestive of various pathogenic roles of NMO-IgG
by: Min, J, et al.
Published: (2010)

Cerebrospinal fluid/serum gradient of IgG is associated with disability at acute attacks of neuromyelitis optica.
by: Kim, S, et al.
Published: (2011)

Neutrophil protease inhibition reduces NMO-IgG-induced damage in mouse brain
by: Papadopoulos, M, et al.
Published: (2011)

Frequency of Aqp4-Ab in patients with neuromyelitis optica (Devic's syndrome) is higher than predicted by NMO-IgG testing
by: Jarius, S, et al.
Published: (2007)

IgG subclasses of disease-specific antibodies and complement activation in vitro in myasthenia gravis and neuromyelitis optica
by: Jacob, S, et al.
Published: (2007)

IgG1 antibodies to acetylcholine receptors in 'seronegative' myasthenia gravis.
by: Leite, M, et al.
Published: (2008)

Complement activation in patients with neuromyelitis optica
by: Nytrova, P, et al.
Published: (2014)

Complement activation in patients with neuromyelitis optica.
by: Nytrova, P, et al.
Published: (2014)

Sequential voltage-gated potassium channel and aquaporin-4 antibodies in a patient with seropositive myasthenia gravis, limbic encephalitis and neuromyelitis optica
by: Jacobson, L, et al.
Published: (2008)

Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
by: Min, J, et al.
Published: (2013)

Inhibition of acetylcholine receptor function by seronegative myasthenia gravis non-IgG factor correlates with desensitisation.
by: Spreadbury, I, et al.
Published: (2005)

T cell deficiency does not reduce lesions in mice produced by intracerebral injection of NMO-IgG and complement.
by: Saadoun, S, et al.
Published: (2011)

IgG-specific cell-based assay detects potentially pathogenic MuSK-Abs in seronegative MG
by: Huda, S, et al.
Published: (2017)

NMO-IgG/Aqp4-Ab belongs to the IgG1 subclass and activates complement in vitro
by: Jarius, S, et al.
Published: (2007)

Characterization of neuromyelitis optica and neuromyelitis optica spectrum disorder patients with a late onset.
by: Collongues, N, et al.
Published: (2013)

Paediatric neuromyelitis optica: clinical, MRI of the brain and prognostic features.
by: Absoud, M, et al.
Published: (2014)

IgG from "seronegative" myasthenia gravis patients binds to a muscle cell line, TE671, but not to human acetylcholine receptor.
by: Blaes, F, et al.
Published: (2000)

Deteksi IgG
by: , SUHARTI, Netti, et al.
Published: (2001)

Status of diagnostic approaches to AQP4-IgG seronegative NMO and NMO/MS overlap syndromes
by: Juryńczyk, M, et al.
Published: (2015)

Neuromyelitis optica in patients with gluten sensitivity associated with antibodies to aquaporin-4.
by: Jarius, S, et al.
Published: (2008)

The borderland of neuromyelitis optica.
by: Matthews, L, et al.
Published: (2009)

IgG4 autoantibodies and autoantigens in the context of IgG4-autoimmune disease and IgG4-related disease
by: Motta, RV, et al.
Published: (2024)

Detrimental role of granulocyte-colony stimulating factor in neuromyelitis optica: clinical case and histological evidence.
by: Jacob, A, et al.
Published: (2012)

Comparison of IgG-ELISA and IgG4-ELISA for Toxocara serodiagnosis
by: Noordin, R., et al.
Published: (2005)

Antibodies to aquaporin-1 are not present in neuromyelitis optica
by: Waters, P, et al.
Published: (2015)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters
by: Koneczny, I, et al.
Published: (2013)

MuSK myasthenia gravis IgG4 disrupts the interaction of LRP4 with MuSK but both IgG4 and IgG1-3 can disperse preformed agrin-independent AChR clusters.
by: Koneczny, I, et al.
Published: (2013)

Phenotypic differences between IgG4 + and IgG 1 + B cells point to distinct regulation of the IgG 4 response
by: Lighaam, L, et al.
Published: (2014)

Phenotypic differences between IgG4+ and IgG1+ B cells point to distinct regulation of the IgG4 response.
by: Lighaam, L, et al.
Published: (2014)

The evolving clinical spectrum of neuromyelitis optica
by: Viegas, S, et al.
Published: (2008)